STEM Learning has announced that MedImmune, the global biologics R&D arm of AstraZeneca, will become the latest supporter to join our campaign to improve young people’s outcomes in science, technology, engineering and mathematics (STEM) subjects.
MedImmune’s support will enable a group of schools and colleges close to its Cambridge R&D facility to participate in an ENTHUSE Partnership – a two-year programme to improve young people’s STEM knowledge, skills, confidence and career aspirations, benefitting over 4,000 young people in Essex.
The schools participating in the ENTHUSE Partnership will benefit from all the opportunities STEM Learning has to offer, both locally and nationally, including STEM-specific professional development for teachers, working with STEM Ambassadors, building STEM Clubs, taking part in the STEM Insight work experience programme and guided access to STEM Learning’s unrivalled collection of resources.
Formal evaluation has shown that ENTHUSE Partnerships provide significant benefits for teachers and young people: improving STEM teaching and teacher retention and increasing young people’s interest and attainment in STEM, as well as awareness of STEM careers.
STEM Learning and MedImmune are committed to encouraging more pupils, from all backgrounds, to progress in STEM studies and careers.
Jacqui Hall, VP Learning, Standards and Insights at MedImmune, said:
“Our participation in an ENTHUSE Partnership represents an extension of our commitment to supporting STEM education for young people by supporting the professional development of their teachers, who can in turn inspire more young students to take up the STEM subjects in their future careers.”